Literature DB >> 22706192

Brucellosis laboratory tests in Syria: what are their diagnostic efficacies in different clinical manifestations?

Yara Alsayed1, Fawza Monem.   

Abstract

INTRODUCTION: Diagnosis of brucellosis in Syria is based on the presence of compatible symptoms in addition to positive agglutination results. This study investigated the potential of culture, ELISA and real-time PCR to support the diagnosis in different clinical manifestations of brucellosis.
METHODOLOGY: Peripheral blood samples from 34 suspected brucellosis patients and 42 probable chronic or relapsed brucellosis patients were tested by agglutination tests, culture, ELISA and real-time PCR.
RESULTS: Among 34 samples collected from suspected cases, 18/34 (53%) were agglutination tests positive, 12/34 (35%) were culture positive, 12/34 (35%) were Brucella IgG positive, and 10/34 (29%) were real-time PCR positive. Three out of 34 patients were positive by real-time PCR but not by agglutination tests or culture. Among 42 samples obtained from probable chronic or relapsed patients, 27/42 (64%) were agglutination tests positive, 26/42 (62%) were Brucella IgG positive, 4/42 (10%) were culture positive, and 1/42 (2%) was real-time PCR positive.
CONCLUSION: To rule in or rule out the diagnosis of brucellosis, a combination of several tests should be applied. Agglutination tests should be performed first considering their high sensitivity. If the agglutination test is negative, real-time PCR, and/or ELISA, and/or culture should be performed. When relapse or chronic brucellosis are suspected, agglutination tests and/or ELISA are recommended.

Entities:  

Mesh:

Year:  2012        PMID: 22706192     DOI: 10.3855/jidc.2453

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  6 in total

1.  Comparison of Different Laboratory Methods for Clinical Detection of Brucella Infection.

Authors:  B Suo; J He; C Wu; D Wang
Journal:  Bull Exp Biol Med       Date:  2021-12-02       Impact factor: 0.804

2.  Detection of IgM antibrucella antibody in the absence of IgGs: a challenge for the clinical interpretation of brucella serology.

Authors:  Julián Solís García Del Pozo; Santiago Lorente Ortuño; Elena Navarro; Javier Solera
Journal:  PLoS Negl Trop Dis       Date:  2014-12-04

3.  Epidemiological and Clinical Features of Brucellosis in the Country of Georgia.

Authors:  Tamar Akhvlediani; Christian T Bautista; Natalia Garuchava; Lia Sanodze; Nora Kokaia; Lile Malania; Nazibrola Chitadze; Ketevan Sidamonidze; Robert G Rivard; Matthew J Hepburn; Mikeljon P Nikolich; Paata Imnadze; Nino Trapaidze
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

4.  Brucellosis in Patients with Crimean-Congo Hemorrhagic Fever.

Authors:  Fazilet Duygu; Tugba Sari; Turan Kaya; Nermin Bulut
Journal:  J Arthropod Borne Dis       Date:  2017-12-30       Impact factor: 1.198

5.  Chronic Brucellosis in Japan.

Authors:  Naoki Kawakami; Yoko Wakai; Kazuhito Saito; Koichi Imaoka
Journal:  Intern Med       Date:  2019-11-01       Impact factor: 1.271

Review 6.  Polymerase chain reaction-based assays for the diagnosis of human brucellosis.

Authors:  Ying Wang; Zhanli Wang; Yaxian Zhang; Liyun Bai; Yue Zhao; Chunfang Liu; An Ma; Hui Yu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-08-01       Impact factor: 3.944

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.